Clinical Trial Update: Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating spatial fragmentation with low-dose radiotherapy in combination with immunotherapy and chemotherapy for chemo-resistant locally advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Lung Cancers, Radiation Treatment for Tumors | Phase 2 | Status: RECRUITING